58
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Neovascular age-related macular degeneration without drusen in the fellow eye: clinical spectrum and therapeutic outcome

, , , , , , , , & show all
Pages 63-70 | Published online: 21 Dec 2016

References

  • de JongPTAge-related macular degenerationN Engl J Med20063551474148517021323
  • BirdACBresslerNMBresslerSBAn international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study GroupSurv Ophthalmol1995393673747604360
  • FerrisFL3rdWilkinsonCPBirdAClinical classification of age-related macular degenerationOphthalmology201312084485123332590
  • FreundKBZweifelSAEngelbertMDo we need a new classification for choroidal neovascularization in age-related macular degeneration?Retina2010301333134920924258
  • BresslerNMBresslerSBWestSKFineSLTaylorHRThe grading and prevalence of macular degeneration in Chesapeake Bay watermenArch Ophthalmol19891078478522786408
  • KleinRKleinBELintonKLPrevalence of age-related maculopathy. The Beaver Dam Eye StudyOphthalmology1992999339431630784
  • MitchellPSmithWAtteboKWangJJPrevalence of age-related maculopathy in Australia. The Blue Mountains Eye StudyOphthalmology1995102145014609097791
  • VingerlingJRDielemansIHofmanAThe prevalence of age-related maculopathy in the Rotterdam StudyOphthalmology19951022052107862408
  • GroupMPSRisk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degenerationArch Ophthalmol19971157417479194725
  • SolomonSDJefferysJLHawkinsBSBresslerNMIncident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No 20 from the Submacular Surgery Trials Research GroupArch Ophthalmol20071251323133017923538
  • KleinRMyersCELeeKESmall drusen and age-related macular degeneration: The Beaver Dam Eye StudyJ Clin Med20154425440
  • AgarwalASaundersGass’ Atlas of Macular Diseases5th edPhiladelphiaElsevier201292100
  • YannuzziLSaundersThe Retinal AtlasLondonElsevier2010568577
  • MitchellPKorobelnikJFLanzettaPRanibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trialsBr J Ophthalmol20109421319443462
  • GregoriNZFeuerWRosenfeldPJNovel method for analyzing snellen visual acuity measurementsRetina2010301046105020559157
  • BohniSCBittnerMHowellJPBachmannLMFaesLSchmidMKComparison of Eylea(R) with Lucentis(R) as first-line therapy in patients with treatment-naive neovascular age-related macular degeneration in real-life clinical practice: retrospective case-series analysisBMC Ophthalmol20151510926289356
  • MartinDFMaguireMGFineSLRanibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year resultsOphthalmology20121191388139822555112
  • HoggREChakravarthyUVisual function and dysfunction in early and late age-related maculopathyProg Retin Eye Res20062524927616580242
  • MarsigliaMBodduSChenCYCorrelation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degenerationRetina20153596697425627089
  • KangSWLeeHBaeKShinJYKimSJKimJMKorean Age-related Maculopathy Study (KARMS) GroupInvestigation of precursor lesions of polypoidal choroidal vasculopathy using contralateral eye findingsGraefes Arch Clin Exp Ophthalmol Epub201695
  • HatzKPrunteCPolypoidal choroidal vasculopathy in Caucasian patients with presumed neovascular age-related macular degeneration and poor ranibizumab responseBr J Ophthalmol20149818819424246375
  • SchatzHMadeiraDJohnsonRNMcDonaldHRCentral serous chorioretinopathy occurring in patients 60 years of age and olderOphthalmology19929963671741142
  • SchlanitzFGBaumannBKundiMDrusen volume development over time and its relevance to the course of age-related macular degenerationBr J Ophthalmol2016
  • AndersonDHRadekeMJGalloNBThe pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visitedProg Retin Eye Res2010299511219961953
  • CurcioCAPresleyJBMalekGMedeirosNEAveryDVKruthHSEsterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathyExp Eye Res20058173174116005869
  • CurcioCAPresleyJBMillicanCLMedeirosNEBasal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particlesExp Eye Res20058076177515939032
  • PikulevaIACurcioCACholesterol in the retina: the best is yet to comeProg Retin Eye Res201441648924704580
  • SarksSCherepanoffSKillingsworthMSarksJRelationship of basal laminar deposit and membranous debris to the clinical presentation of early age-related macular degenerationInvest Ophthalmol Vis Sci20074896897717325134
  • CiardellaAPDonsoffIMHuangSJCostaDLYannuzziLAPolypoidal choroidal vasculopathySurv Ophthalmol200449253714711438
  • LafautBALeysAMSnyersBRasquinFDe LaeyJJPolypoidal choroidal vasculopathy in CaucasiansGraefes Arch Clin Exp Ophthalmol200023875275911045343
  • ImamuraYEngelbertMIidaTFreundKBYannuzziLAPolypoidal choroidal vasculopathy: a reviewSurv Ophthalmol20105550151520850857
  • BalaratnasingamCLeeWKKoizumiHDansinganiKInoueMFreundKBPolypoidal choroidal vasculopathy: a distinct disease or manifestation of many?Retina2016361826414957
  • LaudeACackettPDVithanaENPolypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease?Prog Retin Eye Res201029192919854291
  • CoscasGLupidiMCoscasFToward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degenerationInvest Ophthalmol Vis Sci2015563187319526024102